These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35603204)

  • 1. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.
    Ding Q; Gao Z; Chen K; Zhang Q; Hu S; Zhao L
    Front Immunol; 2022; 13():883410. PubMed ID: 35603204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Epigenetics in Type 1 Diabetes.
    Xie Z; Chang C; Huang G; Zhou Z
    Adv Exp Med Biol; 2020; 1253():223-257. PubMed ID: 32445098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
    Naidoo V; Naidoo M; Ghai M
    Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of β Cell Identity and Dysfunction.
    Sun X; Wang L; Obayomi SMB; Wei Z
    Front Endocrinol (Lausanne); 2021; 12():725131. PubMed ID: 34630329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
    Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
    Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
    Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
    Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in genetic and epigenetic research on type 2 diabetes.
    Kwak SH; Park KS
    Exp Mol Med; 2016 Mar; 48(3):e220. PubMed ID: 26964836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?
    Ling C; Bacos K; Rönn T
    Nat Rev Endocrinol; 2022 Jul; 18(7):433-448. PubMed ID: 35513492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modification in Macrophages: A Promising Target for Tumor and Inflammation-associated Disease Therapy.
    Sun P; Zhang SJ; Maksim S; Yao YF; Liu HM; Du J
    Curr Top Med Chem; 2019; 19(15):1350-1362. PubMed ID: 31215380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.
    Ahmed SAH; Ansari SA; Mensah-Brown EPK; Emerald BS
    Clin Epigenetics; 2020 Jul; 12(1):104. PubMed ID: 32653024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in diabetic cardiomyopathy.
    Ma X; Mei S; Wuyun Q; Zhou L; Sun D; Yan J
    Clin Epigenetics; 2024 Apr; 16(1):52. PubMed ID: 38581056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.
    Sommese L; Zullo A; Mancini FP; Fabbricini R; Soricelli A; Napoli C
    Epigenetics; 2017 Jun; 12(6):401-415. PubMed ID: 28059593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic-epigenetic nexus in type 2 diabetes mellitus.
    Davison GW; Irwin RE; Walsh CP
    Free Radic Biol Med; 2021 Jul; 170():194-206. PubMed ID: 33429021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Promoter Methylation of Macrophage Genes Is Associated With Impaired Vascular Growth in Ischemic Muscles of Hyperlipidemic and Type 2 Diabetic Mice: Genome-Wide Promoter Methylation Study.
    Babu M; Durga Devi T; Mäkinen P; Kaikkonen M; Lesch HP; Junttila S; Laiho A; Ghimire B; Gyenesei A; Ylä-Herttuala S
    Circ Res; 2015 Jul; 117(3):289-99. PubMed ID: 26085133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.
    Karabaeva RZ; Vochshenkova TA; Mussin NM; Albayev RK; Kaliyev AA; Tamadon A
    Front Endocrinol (Lausanne); 2024; 15():1365738. PubMed ID: 38836231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.